Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec:48:48-52.
doi: 10.1016/j.neurobiolaging.2016.08.014. Epub 2016 Aug 24.

Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults

Affiliations

Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults

Julia A Scott et al. Neurobiol Aging. 2016 Dec.

Abstract

Cross-sectional studies show that elevated cerebral amyloid is associated with greater white-matter hyperintensity (WMH) burden in cognitively normal (CN) older adults. However, the relative time courses of amyloid and WMH accrual are unclear. To address this, we tested the associations between known WMH correlates-age, hypertension, and amyloid-with WMH accrual rate. We used brain magnetic resonance imaging to measure WMH change in 112 CN Alzheimer's Disease Neuroimaging Initiative (GO/2) participants over a 2-year period. A linear mixed effects model assessed baseline cerebrospinal fluid amyloid beta (Aβ) 1-42, hypertension, age, and their interactions, as predictors of greater WMH accrual. Greater amyloid burden was associated with greater WMH accrual over time. Those with hypertension showed a stronger association between greater amyloid burden and WMH accrual rate. Greater age was not significantly associated with greater WMH accrual in this model. Although the direction of the relationship cannot be tested in this model, CN individuals harboring cerebral amyloid had greater accrual of WMH over a 2-year period after accounting for hypertension and age. Impaired amyloid clearance and cerebral small vessel disease may both underlie the more rapid emergence of WM lesions. The role of cerebral amyloid burden in white-matter injury should thus be considered as a relevant factor when WMHs are detected clinically.

Keywords: ADNI; Amyloid; FLAIR; Hypertension; MRI; Normal aging.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement

The authors have no conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
Using parameter estimates from Table 2, estimated trends of WMH volume as a function of years from baseline, are shown for prototype individuals for the following categories: normotensive/negative amyloid (blue, dashed), normotensive/positive amyloid (blue, solid), hypertensive/negative amyloid (red, dashed), and hypertensive/positive amyloid (red, solid). Amyloid positive threshold was CSF Aβ1–42 < 192 pg/mL; the amyloid level used in these calculations is the mean for each category. For each, the intercept represents a 74-year-old, APOE ε4 negative male with a high school education, no hyperlipidemia, and average intracranial volume. Abbreviation: WMH, white-matter hyperintensity. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

References

    1. Abraham HM, Wolfson L, Moscufo N, Guttmann CR, Kaplan RF, White WB. Cardiovascular risk factors and small vessel disease of the brain: blood pressure, white matter lesions, and functional decline in older persons. J Cereb Blood Flow Metab. 2016;36:132–142. - PMC - PubMed
    1. Black S, Gao F, Bilbao J. Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke. 2009;40:S48–S52. - PubMed
    1. Brickman AM. Contemplating Alzheimer’s disease and the contribution of white matter hyperintensities. Curr Neurol Neurosci Rep. 2013;13:415. - PMC - PubMed
    1. Carmichael O, Mungas D, Beckett L, Harvey D, Tomaszewski Farias S, Reed B, Olichney J, Miller J, Decarli C. MRI predictors of cognitive change in a diverse and carefully characterized elderly population. Neurobiol Aging. 2012;33:83–95. - PMC - PubMed
    1. D’Avanzo C, Sliwinski C, Wagner SL, Tanzi RE, Kim DY, Kovacs DM. Gamma-secretase modulators reduce endogenous amyloid beta42 levels in human neural progenitor cells without altering neuronal differentiation. FASEB J. 2015;29:3335–3341. - PMC - PubMed

Publication types

Substances